Author： van derWoude C Janneke Hommes Daniel W
Publisher： Informa Healthcare
ISSN： 1471-2598
Source： Expert Opinion on Biological Therapy, Vol.7, Iss.8, 2007-08, pp. : 1233-1243
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Teduglutide in Crohn's disease
Expert Opinion on Biological Therapy, Vol. 13, Iss. 8, 2013-12 ,pp. :
Access to resources
Recommend
Vedolizumab for Crohn's disease
By Mosli Mahmoud H Feagan Brian G
Expert Opinion on Biological Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. :
Infliximab use in Crohn’s disease
By Bewtra Meenakshi Lichtenstein Gary R
Expert Opinion on Biological Therapy, Vol. 5, Iss. 4, 2005-04 ,pp. :
Antitumour necrosis factor therapy in Crohn’s disease
Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. :